These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 21241401

  • 1. Increased COX-2 expression in human vaginal epithelial cells exposed to nonoxynol-9, a vaginal contraceptive microbicide that failed to protect women from HIV-1 infection.
    Zalenskaya IA, Cerocchi OG, Joseph T, Donaghay MA, Schriver SD, Doncel GF.
    Am J Reprod Immunol; 2011 Jun; 65(6):569-77. PubMed ID: 21241401
    [Abstract] [Full Text] [Related]

  • 2. The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission.
    Fichorova RN, Tucker LD, Anderson DJ.
    J Infect Dis; 2001 Aug 15; 184(4):418-28. PubMed ID: 11471099
    [Abstract] [Full Text] [Related]

  • 3. Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives.
    Fichorova RN, Bajpai M, Chandra N, Hsiu JG, Spangler M, Ratnam V, Doncel GF.
    Biol Reprod; 2004 Sep 15; 71(3):761-9. PubMed ID: 15128598
    [Abstract] [Full Text] [Related]

  • 4. A comprehensive murine model to evaluate topical vaginal microbicides: mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety.
    Galen BT, Martin AP, Hazrati E, Garin A, Guzman E, Wilson SS, Porter DD, Lira SA, Keller MJ, Herold BC.
    J Infect Dis; 2007 May 01; 195(9):1332-9. PubMed ID: 17397004
    [Abstract] [Full Text] [Related]

  • 5. Phase I safety & preliminary acceptability of nonoxynol-9 vaginal pessary as a vaginal microbicide in low risk women in Pune, India.
    Joshi S, Joglekar N, Ghate M, Unni J, Risbud A, Bentley M, Shepherd M, Bollinger R, Mehendale S.
    Indian J Med Res; 2003 Apr 01; 117():152-7. PubMed ID: 14604303
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Preclinical assessment of the proinflammatory potential of microbicide candidates.
    Doncel GF, Chandra N, Fichorova RN.
    J Acquir Immune Defic Syndr; 2004 Oct 01; 37 Suppl 3():S174-80. PubMed ID: 16419269
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Colposcopy: still useful in microbicide safety trials?
    Mauck CK, Weiner DH, Lai JJ, Schwartz JL.
    Sex Transm Dis; 2012 Jun 01; 39(6):465-9. PubMed ID: 22592833
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.
    van de Wijgert JH, Kilmarx PH, Jones HE, Karon JM, Chaikummao S.
    Contraception; 2008 Feb 01; 77(2):122-9. PubMed ID: 18226677
    [Abstract] [Full Text] [Related]

  • 12. Understanding factors that modulate HIV infection at the female genital tract mucosae for the rationale design of microbicides.
    Saidi H, Jenabian MA, Belec L.
    AIDS Res Hum Retroviruses; 2012 Nov 01; 28(11):1485-97. PubMed ID: 22867060
    [Abstract] [Full Text] [Related]

  • 13. Vaginal microbicides to prevent human immunodeficiency virus infection in women: perspectives on the female genital tract, sexual maturity and mucosal inflammation.
    Roberts L, Liebenberg L, Barnabas S, Passmore JA.
    Best Pract Res Clin Obstet Gynaecol; 2012 Aug 01; 26(4):441-9. PubMed ID: 22429786
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nonoxyl-9 and women's struggle against HIV.
    Gilmour E.
    AIDS Anal Afr; 1996 Oct 01; 6(5):14. PubMed ID: 12347429
    [Abstract] [Full Text] [Related]

  • 18. Over-the-counter vaginal contraceptive and spermicide drug products containing nonoxynol 9; required labeling. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2007 Dec 19; 72(243):71769-85. PubMed ID: 18159651
    [Abstract] [Full Text] [Related]

  • 19. Vaginal microbicides needed for female-controlled prevention.
    Contracept Technol Update; 1999 Mar 19; 20(3):25-7. PubMed ID: 12321962
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.